BioSpace News Archive

Adlon Therapeutics L.P. announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to update the prescribing information for Adhansia XR.

Black Bird Biotech, Inc. today announced that it has submitted its application to uplist to the OTCQB Venture Market.

Veracyte hat expand and further strengthen the company’s medical team. William A. Bulman, M.D. and Paul Kelly Marcom, M.D, have joined the company as medical director for Lung Cancer and medical director for Breast Cancer, respectively.

ICON plc , (NASDAQ: ICLR) (“ICON”) today announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and clinical research organization.

BioGX, a global provider of molecular diagnostic solutions, announced that the United States Food and Drug Administration has issued Emergency Use Authorization (EUA) for their breakthrough direct sample addition, Xfree™ COVID-19 test.

Recursion, a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, announced that it is doubling the size of its headquarters at The Gateway in downtown Salt Lake City, signing a new lease with Vestar for an additional 100,000 square feet.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the first minimally-invasive heart procedure using its new real-time 3D intracardiac echocardiography (ICE) catheter

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, announced the limited launch and first surgery performed with Anika’s WristMotion® Total Wrist Arthroplasty System.

A Phase 1 study on new drug candidate IDG16177 of novel oral treatment for type 2 diabetes, which is being developed by Ildong Pharmaceutical, is initiated in Germany.

Korea National Institute of Health, Korea’s top research center in the field of hygiene and medicine conducted a field inspection of key companies with mRNA technology.